Ascendis Pharma As Stock Pattern Recognition Two Crows

ASND Stock  USD 225.41  0.69  0.31%   
Ascendis Pharma pattern recognition tool provides the execution environment for running the Two Crows recognition and other technical functions against Ascendis Pharma. Ascendis Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Two Crows recognition function is designed to identify and follow existing trends. Ascendis Pharma momentum indicators are usually used to generate trading rules based on assumptions that Ascendis Pharma trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for Ascendis Pharma AS.

Ascendis Pharma Technical Analysis Modules

Most technical analysis of Ascendis Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ascendis from various momentum indicators to cycle indicators. When you analyze Ascendis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ascendis Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascendis Pharma AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ascendis Pharma AS based on widely used predictive technical indicators. In general, we focus on analyzing Ascendis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ascendis Pharma's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Ascendis Pharma's intrinsic value. In addition to deriving basic predictive indicators for Ascendis Pharma, we also check how macroeconomic factors affect Ascendis Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 2025 2026 (projected)
Payables Turnover0.470.460.410.22
Days Of Inventory On Hand1.7K2.4K2.8K4.4K
Hype
Prediction
LowEstimatedHigh
225.42228.15230.88
Details
Intrinsic
Valuation
LowRealHigh
203.49231.86234.59
Details
Naive
Forecast
LowNextHigh
226.45229.18231.90
Details
16 Analysts
Consensus
LowTargetHigh
252.09277.02307.50
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ascendis Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ascendis Pharma's short interest history, or implied volatility extrapolated from Ascendis Pharma options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Sold over 30 shares
Sector ETFs Idea
Sector ETFs
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Millennials Best Idea
Millennials Best
Invested over 100 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested over 100 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 200 shares
Gold and Gold Mining Idea
Gold and Gold Mining
Invested over 200 shares
Climate Change Idea
Climate Change
Invested over 500 shares
Adviser Favorites Idea
Adviser Favorites
Invested over 60 shares
When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Will Biotechnology sector continue expanding? Could Ascendis diversify its offerings? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ascendis Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(4.64)
Revenue Per Share
10.729
Quarterly Revenue Growth
2.694
Return On Assets
(0.08)
Return On Equity
(8.18)
Understanding Ascendis Pharma AS requires distinguishing between market price and book value, where the latter reflects Ascendis's accounting equity. The concept of intrinsic value—what Ascendis Pharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Ascendis Pharma's price substantially above or below its fundamental value.
Understanding that Ascendis Pharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Ascendis Pharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Ascendis Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.